Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readiness
A cruise ship outbreak of hantavirus has rattled the public and reignited fears of another global health scare as passengers …
Business
Trump policies, China’s biotech boom are ending Europe’s pharma powerhouse era
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on …
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t …
The price of menstrual products is skyrocketing from inflation, tariffs
Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado Ruvic …
GLP-1 drugs are changing how Americans eat. Food companies are racing to catch up
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to a regular-sized …
Inside the booming business of wellness third spaces and membership clubs
A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t …
Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning
As NFL quarterback Boomer Esiason was about to step onto the practice field for the New York Jets in 1993, …
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the …
How the largest health-care education company in U.S. is addressing a growing jobs gap
When Steve Beard took on the role of CEO at higher education firm Adtalem Global Education in 2021, the company …
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | …